New approaches to the treatment of stress urinary incontinence

Advanced Studies in Medicine

Volumn 4, Issue 2 A, 2004, Pages

  Ostergard, Donald R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DULOXETINE; EPHEDRINE; ESTROGEN; MIDODRINE; NORADRENALIN UPTAKE INHIBITOR; OXYBUTYNIN; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; SEROTONIN UPTAKE INHIBITOR; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PRESSURE; BLADDER SPHINCTER; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; EXERCISE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MICTURITION; NAUSEA; NEUROPHYSIOLOGY; PERITONEAL CAVITY; SIDE EFFECT; STRESS INCONTINENCE; URETHRA FUNCTION; URETHRA PRESSURE; URINE FLOW RATE;

EID: 1542350525     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. de Groat WC, Downie JW, Levin RM, et al. Basic neurophysiology and neuropharmacology. In: Abrams P, Khoury S, Wein A, eds. Incontinence. Plymouth, UK: Health Publications Ltd; 1999:105-154.
2. Verma S, Gallagher RM. Evaluating and treating co-morbid pain and depression. Int Rev Psychiatry. 2000;12(2):103-114.
3. Blier P, Abbot FV. Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci. 2001; 26(1):37-43.
4. Morrisan J, Steers WD, Brading A, et al. Neurophysiology and neuropharmacology. In: Khoury S, Abrams P, Wein A, eds. Incontinence. 2nd ed. Plymouth, UK: Health Publications Ltd; 2002:85-163.
5. Thor KB, Katofiasc MA. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, an central neural control of lower urinary tract function in the chloralase-anesthetized female cat. J Pharm Exp Ther. 1995;274(2):1014-1024.
6. Hirakawa S, Hassouna M, Deleon R, Elhilali MM. The role of combined pelvic floor stimulation and biofeedback in female urinary incontinence: early experience. Can J Urol. 1994;1(4):72-77.
7. Harvey MA. Pelvic floor exercises during and after pregnancy: a systematic review of their role in preventing pelvic floor dysfunction. J Obstet Gynaecol Can. 2003;25(6):487-498.
8. Smith JJ 3rd. Intravaginal stimulation randomized trial. J Urol. 1996; 155(1):127-130.
9. Amara JL, Oliveira Gameiro MO, Padavani CR. Treatment of urinary stress incontinence by intravaginal electrical stimulation and pelvic floor physiotherapy. Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14(3):204-208.
10. Indrekvam S, Hunskaar S. Side effects, feasibility, and adherence to treatment during home-managed electrical stimulation for urinary incontinence: a Norwegian national cohort of 3198 women. Neurourol Urodyn. 2002;21(6):546-552.
11. Dolman M. Electromuscular stimulation for urinary incontinence: Levatar 100. Br J Community Nurs. 2000; 5(5):214-215, 217-220.
12. Weber AM, Walters MD. Burch procedure compared with sling for stress urinary incontinence: a decision analysis. Obstet Gynecol. 2000;96(6):867-873.
13. Jarvis G et al. Surgical treatment for incontinence in adult women: surgery of female lower genito-urinary fistulae. In: Abrams P, Khoury S, Wein A, eds. Incontinence. Plymouth, UK: Health Publications Ltd; 1999.
14. Agency for Healthcare, Policy and Research. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline No. 2 (update). Rockville, Md: US Department of Health and Human Services, Public Health Service, AHCPR; 1996. AHCPR publication 96-0682.
15. Smith ARB et al. Surgical treatment: women. Presented at: the 2nd International Consultation on Incontinence; July 1-3, 2001; Paris, France.
16. Bai SW, Roh JL, Kim JY, Kyung AC, Kim SK, Park KH. Outcomes and surgical therapeutic index of Burch colposuspension in stress urinary incontinence. J Reprod Med. 2003;48(2):102-106.
17. Colombo M, Scalambrino S, Maggioni A, Milani R. Burch colposuspension versus modified Marshall-Marchetti-Krantz urethropexy for primary genuine stress urinary incontinence: a prospective, randomized clinical trial. Am J Obstet Gynecol. 1994;171(6):1573-1579.
18. Bergman A, Elia G. Three surgical procedures for genuine stress incontinence. Five-year follow-up of a prospective randomized study. Am J Obstet Gynecol. 1995;173(1):66-71.
19. Colombo M, Vitobello D, Proietti F, Milani R. Randomised comparison of Burch colposuspension versus anterior colporrhaphy in women with stress urinary incontinence and anterior vaginal wall prolapse. BJOG. 2000;107(4):544-51.
20. Ward K, Hilton P, United Kingdom and Ireland Tension-Free Vaginal Tape Trial Group. Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ. 2002;325(7355):789-790.
21. Al-Badr A, Ross S, Soroka D, Drutz HP. What is the available evidence for hormone replacement therapy in women with stress urinary incontinence? J Obstet Gynaecol Can 2003;25(7):567-574.
22. de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997; 50(suppl 6A):36-52.
23. Alhasso A, Glazener CM, Pickard R, N'Dow J. Adrenergic drugs for urinary incontinence in adults. Cochrane Database Syst Rev. 2003; (2):CD001842.
24. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry. 1996; 57(11):514-518.
25. Castleden CM, Duffin HM, Briggs RS, Ogden BM. Clinical and urodynamic effects of ephedrine in elderly incontinent patients. J Urol. 1982;128(6):1250-1252.
26. Diokno AC, Taub M. Ephedrine in treatment of urinary incontinence. Urology. 1975;5(5):624-625.
27. Weil EH, Eerdmans PH, Dijkman GA, et al. Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study. Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(3):145-150.
28. Dmochowski RR, Miklos JR, Norton PA, et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol. 2003;170(4 pt 1):1259-1263.
29. Patrick DL, Martin ML, Bushnell DM, Yalcin I, Wagner TH, Buesching DP. Quality of life for women with urinary incontinence: further development of the Incontinence Quality of Life Instrument (I-QOL). Urology. 1999;53(1):71-76.
30. Physicians Desk Reference, 2003. Montvale, NJ: Thomson Healthcare; 2003.
31. Norton PA, Zinner NR, Yolcin I, Bump RC. Duloxetine versus placebo in the treatment of stress urinary incontinence. Duloxetine Urinary Incontinence Study Group. Am J Obstet Gynecol. 2002; 187(1):40-48.